TipRanks

TPG GP A, LLC Insider Profile

81 Followers
TPG GP A, LLC, Ten Percent Owner at Lifestance Health Group, holds 79.69M shares in Lifestance Health Group (Ticker: LFST), holds 3.77M shares in Ceribell, Inc. (Ticker: CBLL), holds 3.69M shares in Odyssey Therapeutics, Inc. (Ticker: ODTX). Most recently, TPG GP A, LLC Sold ― shares of Lifestance Health Group on Sep 15, 2026 for an estimated value of $226.26M.
tipranks
TPG GP A, LLC

TPG GP A, LLC
Lifestance Health Group (LFST)
Ten Percent Owner

Ranked #714 out of 109,030 Corporate Insiders

Profitable Transactions

64%
29 out of 45 Profitable Transactions

Average Return

+31.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4B
27.21%
22.69%
12.75%
8.65%
28.70% Others
A breakdown of TPG GP A, LLC's holdings

Insider Roles

Lifestance Health Group
(LFST)
Ten Percent Owner
Life Time Group Holdings
(LTH)
Former 10% Owner
Nextpower Inc
(NXT)
Ten Percent Owner
BETA Technologies, Inc. Class A
(BETA)
Former 10% Owner
+13 other positions
Roles that TPG GP A, LLC holds in companies

Most Profitable Insider Trade

Stock:
Sionna Therapeutics, Inc.
(SION)
Rating:Informative Buy
Date:Jul 01, 2025 - Jul 01, 2026
Return:+134.50%
The most profitable trade made by TPG GP A, LLC

TPG GP A, LLC's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Lifestance Health Group
Sep 15, 2026
Ten Percent Owner
Informative Sell
226.26M
$1.07B
Life Time Group Holdings
Jun 10, 2025
Former 10% Owner
Informative Sell
245.16M
$888.93M
Bicara Therapeutics Inc.
Sep 18, 2024
Former 10% Owner
Uninformative Buy
$45.48M
Ceribell, Inc.
Jun 30, 2026
Former 10% Owner
Informative Sell
4.07M
$91.60M
ServiceTitan, Inc. Class A
Dec 17, 2024
Former 10% Owner
Uninformative Buy
$301.29M
Sionna Therapeutics, Inc.
Jan 26, 2026
Ten Percent Owner
Informative Sell
10.00M
$53.65M
Tpg Re Finance
Aug 07, 2025
Former 10% Owner
Uninformative Sell
$18.29M
BETA Technologies, Inc. Class A
Nov 07, 2025
Former 10% Owner
Uninformative Buy
$339.06M
Odyssey Therapeutics, Inc.
May 13, 2026
Former 10% Owner
Uninformative Buy
$89.52M
Trevi Therapeutics
Jul 06, 2022
Former 10% Owner
Informative Sell
1.44M
$60.78M
Cushman & Wakefield
May 24, 2024
Former 10% Owner
Informative Sell
188.08M
$0.00
Progyny
Aug 09, 2023
Former 10% Owner
Informative Sell
119.13M
$176.85M
Amneal Pharmaceuticals
Dec 14, 2022
Former 10% Owner
Informative Sell
9.09M
$212.30M
Nerdy
Nov 14, 2024
Former Director & 10% Owner
Uninformative Sell
$74.63M
TPG
Ten Percent Owner
Super League Enterprise
Aug 17, 2023
Former 10% Owner
Informative Sell
1.69M
$0.00
Nextpower Inc
Feb 07, 2024
Ten Percent Owner
Informative Sell
622.60M
$499.43M
List of latest transactions for each holding click on a transaction to see TPG GP A, LLC's performance on stock

TPG GP A, LLC insider profile FAQ

What is the percentage of profitable transactions made by TPG GP A, LLC?
The percentage of profitable transactions made by TPG GP A, LLC is 64%.
    What is the average return per transaction made by TPG GP A, LLC?
    The average return per transaction made by TPG GP A, LLC is 31.70%.
      What stocks does TPG GP A, LLC hold?
      TPG GP A, LLC holds: LFST, LTH, BCAX, CBLL, TTAN, SION, TRTX, BETA, ODTX, TRVI, CWK, PGNY, AMRX, NRDY, TPG, SLE, NXT stocks.
        What was TPG GP A, LLC’s latest transaction?
        TPG GP A, LLC latest transaction was an Informative Sell of $226.26M.
          What was TPG GP A, LLC's most profitable transaction?
          TPG GP A, LLC’s most profitable transaction was an Informative Buy of SION stock on July 1, 2025. The return on the trade was 134.50%.
            What is TPG GP A, LLC's role in Lifestance Health Group?
            TPG GP A, LLC's role in Lifestance Health Group is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.